Key features and details
- FITC Goat polyclonal to Influenza A Virus
- Suitable for: ICC/IF, IHC-P
- Reacts with: Influenza A
- Conjugation: FITC. Ex: 493nm, Em: 528nm
- Isotype: IgG
Product nameFITC Anti-Influenza A Virus antibody
See all Influenza A Virus primary antibodies
DescriptionFITC Goat polyclonal to Influenza A Virus
ConjugationFITC. Ex: 493nm, Em: 528nm
SpecificityPurified virions. Specific to H1N1 by IHA. Does not react with HEp-2 cells. May cross-react with Chicken cellular proteins. Does not cross-react with Influenza B, RSV, Para 1-3 or Adenovirus.
Tested applicationsSuitable for: ICC/IF, IHC-Pmore details
Species reactivityReacts with: Influenza A
Influenza A Strain USSR (H1N1)
General notesKeep in the dark.
Covalently coupled with high purity Isomer I of fluorescein isothiocyanate. Care is taken to ensure complete removal of any free fluorescein from the final product.
Storage instructionsShipped at 4°C. Store at +4°C.
Storage bufferPreservative: 0.1% Sodium azide
Constituents: 0.0268% PBS, 1% BSA
Concentration information loading...
Our Abpromise guarantee covers the use of ab20388 in the following tested applications.
IHC-P: Use at an assay dependent dilution.
Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
RelevanceInfluenza A and B are the two types of influenza viruses that cause epidemic human disease. Influenza type C infections cause a mild respiratory illness and are not thought to cause epidemics. Influenza A viruses are further categorized into subtypes on the basis of two surface antigens: hemagglutinin (H) and neuraminidase (N). Strains are also described by geographic origin, strain number and year of isolation.
ab20388 has been referenced in 2 publications.
- Jacquet N et al. Hydrophobin fusion of an influenza virus hemagglutinin allows high transient expression in Nicotiana benthamiana, easy purification and immune response with neutralizing activity. PLoS One 9:e115944 (2014). PubMed: 25541987
- Nakayama M et al. Protection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccine. PLoS One 8:e82740 (2013). PubMed: 24376571